The inhaled phosphodiesterase 4 inhibitor GSK256066 reduces allergen challenge responses in asthma
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1465-993X
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
The inhaled phosphodiesterase 4 inhibitor GSK256066 reduces allergen challenge responses in asthma ; volume:11 ; number:1 ; day:1 ; month:3 ; year:2010 ; pages:1-9 ; date:12.2010
Respiratory research ; 11, Heft 1 (1.3.2010), 1-9, 12.2010
- Creator
-
Singh, Dave
- Contributor
-
Petavy, Frank
Macdonald, Alex J.
Lazaar, Aili L.
O'Connor, Brian J.
SpringerLink (Online service)
- DOI
-
10.1186/1465-9921-11-26
- URN
-
urn:nbn:de:1111-2016060311712
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:52 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Singh, Dave
- Petavy, Frank
- Macdonald, Alex J.
- Lazaar, Aili L.
- O'Connor, Brian J.
- SpringerLink (Online service)
Other Objects (12)
Poster 1007: Universal allergen particle generation for inhaled allergen challenges in the fraunhofer environmental challenge chamber (ECC)
Plasma proteome changes linked to late phase response after inhaled allergen challenge in asthmatics
Oral and inhaled p38 MAPK inhibitors: effects on inhaled LPS challenge in healthy subjects
Combined fluticasone furoate/vilanterol reduces decline in lung function following inhaled allergen 23 h after dosing in adult asthma: a randomised, controlled trial
Use of a vibrating mesh nebulizer for allergen challenge
Allergen inhalation challenge, refractoriness and the effects of ibuprofen
Exhaled nitric oxide decreases after positive food-allergen challenge
Lung vasodilatory response to inhaled iloprost in experimental pulmonary hypertension: amplification by different type phosphodiesterase inhibitors
A dose-ranging study of the inhaled dual phosphodiesterase 3 and 4 inhibitor ensifentrine in COPD
Functional genomics of the peripheral blood response to allergen inhalation challenge
The effect of the novel phosphodiesterase-4 inhibitor MEM 1414 on the allergen induced responses in mild asthma
Allergen-Immuntherapie
Poster 1007: Universal allergen particle generation for inhaled allergen challenges in the fraunhofer environmental challenge chamber (ECC)
Plasma proteome changes linked to late phase response after inhaled allergen challenge in asthmatics
Oral and inhaled p38 MAPK inhibitors: effects on inhaled LPS challenge in healthy subjects
Combined fluticasone furoate/vilanterol reduces decline in lung function following inhaled allergen 23 h after dosing in adult asthma: a randomised, controlled trial
Use of a vibrating mesh nebulizer for allergen challenge
Allergen inhalation challenge, refractoriness and the effects of ibuprofen
Exhaled nitric oxide decreases after positive food-allergen challenge
Lung vasodilatory response to inhaled iloprost in experimental pulmonary hypertension: amplification by different type phosphodiesterase inhibitors
A dose-ranging study of the inhaled dual phosphodiesterase 3 and 4 inhibitor ensifentrine in COPD
Functional genomics of the peripheral blood response to allergen inhalation challenge
The effect of the novel phosphodiesterase-4 inhibitor MEM 1414 on the allergen induced responses in mild asthma
Allergen-Immuntherapie
Poster 1007: Universal allergen particle generation for inhaled allergen challenges in the fraunhofer environmental challenge chamber (ECC)
Plasma proteome changes linked to late phase response after inhaled allergen challenge in asthmatics
Oral and inhaled p38 MAPK inhibitors: effects on inhaled LPS challenge in healthy subjects
Combined fluticasone furoate/vilanterol reduces decline in lung function following inhaled allergen 23 h after dosing in adult asthma: a randomised, controlled trial
Use of a vibrating mesh nebulizer for allergen challenge
Allergen inhalation challenge, refractoriness and the effects of ibuprofen
Exhaled nitric oxide decreases after positive food-allergen challenge
Lung vasodilatory response to inhaled iloprost in experimental pulmonary hypertension: amplification by different type phosphodiesterase inhibitors
A dose-ranging study of the inhaled dual phosphodiesterase 3 and 4 inhibitor ensifentrine in COPD
Functional genomics of the peripheral blood response to allergen inhalation challenge
The effect of the novel phosphodiesterase-4 inhibitor MEM 1414 on the allergen induced responses in mild asthma